Top Clinical Trials companies in Ireland by EBITDA
Ireland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.52 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
| 2 |
USD -605.96 K
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
| 3 |
USD -34.58 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
|
| 4 |
USD -41.15 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
| 5 |
USD -190.11 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
| 6 |
USD -192.72 M
|
Dec. 31, 2023 | USD 3.72 | -0.53% |
|
Ireland |
Frequently Asked Questions
-
Which Clinical Trials company in Ireland has the highest EBITDA ?
The Clinical Trials company in Ireland with the highest EBITDA is ICON Public Limited Company (NasdaqGS: ICLR) at USD 1.52 B.
-
Which Clinical Trials company in Ireland has the lowest EBITDA ?
The Clinical Trials company in Ireland with the lowest EBITDA is Mural Oncology plc (NasdaqGM: MURA) at USD -192.72 M.
-
What are the top 10 Clinical Trials companies in Ireland by EBITDA ?
The top 10 Clinical Trials companies in Ireland by EBITDA are ICON Public Limited Company, Ovoca Bio plc, Iterum Therapeutics plc, GH Research PLC, Prothena Corporation plc and Mural Oncology plc.
-
What are the bottom 10 Clinical Trials companies in Ireland by EBITDA ?
The bottom 10 Clinical Trials companies in Ireland by EBITDA are Mural Oncology plc, Prothena Corporation plc, GH Research PLC, Iterum Therapeutics plc, Ovoca Bio plc and ICON Public Limited Company.